tiprankstipranks
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market

Avidity Biosciences (RNA) Insider Trading Activity

441 Followers
Trend: Corporate Insiders placed Informative Sells of Shares Worth $542.2K in the Last 3 Months

RNA Insider Transactions

The data in the graph is based on publicly available reports of insider transactions, as reported to the SEC.
See the number of buy and sell transactions by insiders for this stock over the past year.

Insider Confidence Signal

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on 1 informative insider transactions from the last 3 months.
The sentiment expressed in the Insider Confidence Signal is based on insider transactions over the past 3 months.

Insider Buy and Sell Transactions​

Insider Profile
Role
Transaction
Description
No. of Shares
Amount
Date
Follow
SEC
Upgrade Banner
Director
Uninformative Sell
Auto Sell
5,000
$149450
Director
Uninformative Sell
Auto Sell
5,000
$114100
Director
Informative Sell
Non Open Market Sell
20,000
$542200
Director
Uninformative Sell
Auto Sell
5,000
$119800
Director
Uninformative Sell
Auto Sell
27,641
$608852
Director
Uninformative Sell
Auto Sell
1,859
$18832
Michael MacLean insider transaction on RNA
Michael MacLean
Not Ranked
CFO
Uninformative Sell
Auto Sell
75,000
$2121000
Michael MacLean insider transaction on RNA
Michael MacLean
Not Ranked
CFO
Uninformative Sell
Auto Sell
40,000
$980400
Michael MacLean insider transaction on RNA
Michael MacLean
Not Ranked
CFO
Uninformative Sell
Auto Sell
1,616
$16370
Michael MacLean insider transaction on RNA
Michael MacLean
Not Ranked
CFO
Uninformative Buy
Auto Buy
22,500
$227475

FAQ

Which Insider has made the most Buy and/or Sell transactions on RNA?
The insider who has made the most Buy and/or Sell transactions on RNA is Sarah Boyce.
    What is the difference between informative and uninformative transactions?
    The main difference between informative and uninformative transactions is that informative ones reflect sentiment, so they are worth paying attention to.

    Corporate insiders are often awarded stock options as part of their compensation packages; this gives them the right to buy shares at a set price for a finite period. When an insider buys stocks because they are receiving a grant of shares for retention purposes, the Buy does not reveal what they think about the company’s prospects. Therefore, this type of transaction is considered an uninformative Buy transaction. It does not reflect sentiment and is of little value to investors.

    On the other hand, there is usually only one reason that an insider uses their personal funds to buy stocks of their company on the open market: they believe that the share price is going to rise. This is an informative transaction that provides valuable information to investors.

    Likewise, there are informative and uninformative Sell transactions, too. However, it can be more difficult to understand motive when it comes to informative Sell transactions, as they may reflect need; for example, an insider might decide to sell to pay for a new car, rather than because they have a pessimistic outlook on the stock.

    By law, corporate insiders are required to disclose trades they make in their own company to the U.S. Securities and Exchange Commission (SEC). Our technology scans these the Form 4 filings, and using the information on the form, determines whether the Buy or Sell transactions are informative or uninformative.
      When was the last time an insider traded RNA?
      The last RNA insider trade was on May 21, 2024.
        What was the highest value insider transaction for RNA during the last quarter?
        The highest value insider transaction for RNA during the last quarter is $2,429,560, Uninformative Sell.
          Can I see which stocks the top-ranking insiders are Buying or Selling?
          Yes, head over to our Expert Center to see a list of the top 100 corporate insiders and follow the insiders of your choice. Visit their profiles for more details about their transactions and see how they perform on a stock-by-stock basis.
            Who is Avidity Biosciences Inc CEO?
            RNA's CEO is Sarah Boyce.
              Which Avidity Biosciences Inc executives are trading RNA stocks?
              Arthur Levin, Michael MacLean and Sarah Boyce at Avidity Biosciences Inc are trading RNA stocks.
                What is RNA's Insider Trend?
                In the last 3 months corporate insiders have Sold shares worth $542.2K.
                  What is the meaning of the following actions:
                  Non Open Market Buy: An agreement to purchase shares made directly with a company from the company’s own inventory of shares. Example: An insider executes on an option to buy shares from the company whereas the transaction does not occur through an exchange.

                  Non Open Market Sell: Similarly to a Non Open Market Buy, this transaction does not occur through an exchange and is an agreement made with a company.

                  Grant/Award/Other Acquisition: An Award or grant are both forms of financial assistance, typically for a public purpose provided by the federal government after a contractual agreement is made resulting in an upfront payment to complete agreed upon work.

                  Auto Buy: A transaction which was initiated and completed automatically often allowing investors to purchase shares of a stock in regularly without manually confirming the buy order.

                  Auto Sell: A transaction which was initiated and completed automatically to sell a security without manually confirming the sell order.

                  Options Exercised and fully Sold: In regards to options trading, exercising an option means proceeding to buy or sell a specified security within an options contract.
                    Amount: When there is an accurate amount available in the form 4 filing, it will be shown. If an accurate amount is not available, we will show the Estimated Value which is a unique TipRanks calculation that shows the financial impact of insider transactions on a company. It is calculated by multiplying the number of shares an insider buys or sells by the closing price of the company's stock on the day the transaction forms are filed.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis